デフォルト表紙
市場調査レポート
商品コード
1623934

人工多能性幹細胞(iPS細胞)の世界市場:業界分析、規模、シェア、成長、動向、予測(2025年~2032年)

Induced Pluripotent Stem Cells Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032


出版日
ページ情報
英文 271 Pages
納期
2~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
人工多能性幹細胞(iPS細胞)の世界市場:業界分析、規模、シェア、成長、動向、予測(2025年~2032年)
出版日: 2025年01月03日
発行: Persistence Market Research
ページ情報: 英文 271 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の人工多能性幹細胞(iPS細胞)の市場規模は、2025年に32億米ドルになるとみられ、2025年~2032年の予測期間に7.50%のCAGRで拡大し、2032年には53億米ドルに達すると予測されています。

世界のiPS細胞市場は、人工多能性幹細胞(iPSC)に焦点を当てています。iPSCは、薬物試験、疾患モデリング、再生医療、毒性試験に使用される特殊な細胞タイプを生成する能力により、広く重要性を増しています。この市場は、幹細胞研究の継続的な進展とライフサイエンスへの投資増加の影響を受けています。市場の将来的な成長は、疾病開拓、創薬、個別化医療におけるiPSCの役割の理解に注力する学術機関と商業機関の両方によって促進されます。

世界のiPS細胞市場は、様々な要因によって大きな成長を遂げています。特に再生医療や疾患モデリングへの重点が高まっています。幹細胞を用いた治療に注力する企業が増えるにつれ、iPS細胞の需要も高まると予想されます。加えて、iPSC技術の進歩により薬剤スクリーニングが効率化され、動物モデルへの依存度が下がり、前臨床試験が改善されています。さらに、北米や欧州で研究が進んでいることや、患者特異的な薬剤スクリーニングにiPSCを使用する動きが高まっていることも、市場の拡大を後押ししています。また、個別化医療に対する需要も、iPSCsによって患者固有の疾患モデリングや薬剤試験が可能になるため、市場の成長にさらなる弾みをつけると予想されます。

iPS細胞市場は、特にバイオテクノロジーと製薬産業の継続的成長に伴い、大きな機会を提供しています。疾病メカニズムの解明が進む中、iPS細胞は個別化された医薬品開発や疾病治療に独自の機会を提供します。特に大学や研究機関における基礎研究へのさらなる投資により、iPSCをどのように利用すれば疾患プロセスをより深く理解できるのかについての新たな洞察が得られ、新たな治療戦略につながることが期待されます。さらに、毒性試験や臨床試験におけるiPSCの利用拡大も、大きな成長機会をもたらします。バイオテクノロジー企業と研究機関の連携が進むことで、市場の可能性はさらに高まり、iPSCベースの応用分野の商業化が加速しています。

当レポートでは、世界の人工多能性幹細胞(iPS細胞)市場について調査し、細胞タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 人工多能性幹細胞の市場機会分析

第4章 市場背景

第5章 マクロ経済の前提

第6章 世界経済の見通し

第7章 主な内容

第8章 北米の人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)

第9章 ラテンアメリカの人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)

第10章 欧州の人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)

第11章 アジア太平洋の人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)

第12章 中国の人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)

第13章 中東・アフリカの人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)

第14章 予測要因:関連性と影響

第15章 予測の前提条件

第16章 市場構造分析

第17章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 企業の詳細
    • Thermo Fisher Scientific Inc.
    • FUJIFILM Holdings Corporation (Cellular Dynamics)
    • Horizon Discovery Group plc.
    • Takara Bio Inc.
    • Cell Applications, Inc.
    • Lonza Group Ltd.

第18章 世界の人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)、地域別

第19章 世界の人工多能性幹細胞分析(2020年~2024年)および予測(2025年~2032年)、細胞タイプ別

第20章 世界の人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)、用途別

第21章 世界の人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)、エンドユーザー別

第22章 世界の人工多能性幹細胞(iPS細胞)市場分析(2020年~2024年)および予測(2025年~2032年)

第23章 仮定と頭字語

第24章 調査手法

目次
Product Code: PMRREP17968

Persistence Market Research has recently released a comprehensive report on the global iPS Cell Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Induced Pluripotent Stem Cell Market Size (2025E): USD 3.2 Billion
  • Projected Market Value (2032F): USD 5.3 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.50%

Induced Pluripotent Stem Cell Market- Report Scope:

The global iPS cell market is focused on induced pluripotent stem cells (iPSCs), which are gaining widespread importance for their ability to generate specialized cell types used for drug testing, disease modeling, regenerative medicine, and toxicity testing. This market is influenced by ongoing advancements in stem cell research and increasing investments in life sciences. The market's future growth is fueled by both academic and commercial entities' focus on understanding the roles of iPSCs in disease development, drug discovery, and personalized medicine.

Market Drivers:

The global iPS cell market is witnessing significant growth due to various factors. A key driver is the increasing investment in life science research, particularly the growing emphasis on regenerative medicine and disease modeling. With more companies focusing on stem cell-based therapies, the demand for iPSCs is expected to rise. In addition, advancements in iPSC technology have made drug screening more efficient, reducing the reliance on animal models and improving preclinical testing. Moreover, the ongoing research in North America and Europe, as well as the rising use of iPSCs for patient-specific drug screening, supports the expansion of the market. The demand for personalized medicine is also expected to provide further momentum to market growth, as iPSCs allow for patient-specific disease modeling and drug testing.

Market Restraints:

Despite the promising growth trajectory, the iPS cell market faces some hurdles. One of the primary challenges is the complexity and cost associated with iPSC production and maintenance, which may limit accessibility for smaller research institutions or emerging biotech firms. Additionally, ethical concerns surrounding stem cell research, along with stringent regulatory frameworks, can impede market expansion. There is also a need for improved standardization and protocols in iPSC generation, differentiation, and application to ensure consistency and reproducibility in research. These challenges are expected to be addressed through ongoing research, technological improvements, and evolving regulatory support.

Market Opportunities:

The iPS cell market offers substantial opportunities, particularly with the continued growth of the biotechnology and pharmaceutical industries. With an increased understanding of disease mechanisms, iPSCs offer unique opportunities for personalized drug development and disease treatment. Further investment in basic research, especially in academia and research institutes, is expected to provide fresh insights into how iPSCs can be used to better understand disease processes, leading to new therapeutic strategies. Additionally, the growing use of iPSCs in toxicity testing and clinical trials presents significant growth opportunities. The increasing collaboration between biotech firms and research institutes further enhances market potential, accelerating the commercialization of iPSC-based applications.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the iPS cell market?
  • How are advancements in stem cell technology influencing iPS cell-based applications?
  • Which regions are seeing the highest demand for iPS cells in drug testing, regenerative medicine, and toxicity screening?
  • What are the challenges and limitations associated with iPSC technology, and how can these be overcome?
  • Who are the key players in the iPS cell market, and what strategies are they employing to expand their market presence?
  • What are the emerging trends and future projections for the global iPS cell market?

Competitive Intelligence and Business Strategy:

Leading companies in the global iPS cell market are focusing on enhancing their research capabilities and expanding product portfolios. Key players such as FUJIFILM Cellular Dynamics, Stemcell Technologies, and ReproCELL are investing heavily in advancing iPSC technologies and developing solutions tailored to drug discovery and regenerative medicine. Strategic partnerships and collaborations with academic institutions and research organizations play a critical role in accelerating product development and market reach. These companies are also exploring innovative applications of iPSCs in disease modeling and personalized treatments, positioning themselves as leaders in the expanding life sciences field.

Key Companies Profiled:

  • Thermo Fisher Scientific Inc.
  • FUJIFILM Holdings Corporation (Cellular Dynamics)
  • Horizon Discovery Group plc.
  • Takara Bio Inc.
  • Cell Applications, Inc.
  • Lonza Group Ltd.
  • Others.

Induced Pluripotent Stem Cell Market Segmentation:

By Cell Type:

  • Hepatocytes
  • Fibroblasts
  • Keratinocytes
  • Neurons
  • Others

By Application:

  • Drug Development
  • Regenerative Medicine
  • Toxicity Testing

By End User:

  • Academic and Research Institutes
  • Biotechnology Companies

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding China (APEC)
  • China
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Induced Pluripotent Stem cells Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. Parent Market Overview
  • 4.2. Induced Pluripotent Stem Cell Timeline
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Trends

5. Macroeconomic Assumptions

6. Global Economic Outlook

  • 6.1. Gross Domestic Product by Region & Country, 2025 - 2032
  • 6.2. Healthcare Indicators

7. Key Inclusions

  • 7.1. Usage Trend in Industry
  • 7.2. Active Researchers in Stem Cell Research
  • 7.3. Induced Pluripotent Stem Cell Therapy for Cardiovascular Disease
  • 7.4. In-Vivo Modelling for Neurological Disorder Using Induced Pluripotent Stem Cells
  • 7.5. Pipeline Assessment

8. North America Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 8.1. Introduction
  • 8.2. Regional Market Trends
  • 8.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
    • 8.3.1. U.S.
    • 8.3.2. Canada
  • 8.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 8.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
    • 8.5.1. Hepatocytes
    • 8.5.2. Fibroblasts
    • 8.5.3. Keratinocytes
    • 8.5.4. Neurons
    • 8.5.5. Others
  • 8.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
  • 8.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
    • 8.7.1. Drug Development
    • 8.7.2. Toxicity testing
    • 8.7.3. Regenerative Medicine
    • 8.7.4. Others
  • 8.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
  • 8.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 8.9.1. Academic & Research Institutes
    • 8.9.2. Biotechnology companies
    • 8.9.3. Others
  • 8.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 8.11. Drivers and Restraints: Impact Analysis
  • 8.12. Market Attractiveness Analysis
    • 8.12.1. By Country
    • 8.12.2. By Cell Type
    • 8.12.3. By Application
    • 8.12.4. By End User
  • 8.13. Key Market Participants - Intensity Mapping
  • 8.14. Drivers and Restraints - Impact Analysis

9. Latin America Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 9.1. Introduction
  • 9.2. Regional Market Trends
  • 9.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
    • 9.3.1. Argentina
    • 9.3.2. Brazil
    • 9.3.3. Mexico
    • 9.3.4. Rest of Latin America
  • 9.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 9.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
    • 9.5.1. Hepatocytes
    • 9.5.2. Fibroblasts
    • 9.5.3. Keratinocytes
    • 9.5.4. Neurons
    • 9.5.5. Others
  • 9.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
  • 9.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
    • 9.7.1. Drug Development
    • 9.7.2. Toxicity testing
    • 9.7.3. Regenerative Medicine
    • 9.7.4. Others
  • 9.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
  • 9.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 9.9.1. Academic & Research Institutes
    • 9.9.2. Biotechnology companies
    • 9.9.3. Others
  • 9.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 9.11. Drivers and Restraints: Impact Analysis
  • 9.12. Market Attractiveness Analysis
    • 9.12.1. By Country
    • 9.12.2. By Cell Type
    • 9.12.3. By Application
    • 9.12.4. By End User
  • 9.13. Key Market Participants - Intensity Mapping
  • 9.14. Drivers and Restraints - Impact Analysis
  • 9.15. Key Mergers & Acquisitions

10. Europe Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 10.1. Introduction
  • 10.2. Regional Market Trends
  • 10.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
    • 10.3.1. Germany
    • 10.3.2. U.K.
    • 10.3.3. France
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Russia
    • 10.3.7. Rest of Europe
  • 10.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 10.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
    • 10.5.1. Hepatocytes
    • 10.5.2. Fibroblasts
    • 10.5.3. Keratinocytes
    • 10.5.4. Neurons
    • 10.5.5. Others
  • 10.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
  • 10.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
    • 10.7.1. Drug Development
    • 10.7.2. Toxicity testing
    • 10.7.3. Regenerative Medicine
    • 10.7.4. Others
  • 10.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
  • 10.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 10.9.1. Academic & Research Institutes
    • 10.9.2. Biotechnology companies
    • 10.9.3. Others
  • 10.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 10.11. Drivers and Restraints: Impact Analysis
  • 10.12.Market Attractiveness Analysis
    • 10.12.1. By Country
    • 10.12.2. By Cell Type
    • 10.12.3. By Application
    • 10.12.4. By End User
  • 10.13. Key Market Participants - Intensity Mapping
  • 10.14. Drivers and Restraints - Impact Analysis
  • 10.15. Key Mergers & Acquisitions

11. Asia Pacific Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 11.1. Introduction
  • 11.2. Regional Market Trends
  • 11.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
    • 11.3.1. Japan
    • 11.3.2. India
    • 11.3.3. Australia and New Zealand
    • 11.3.4. Rest of Asia Pacific
  • 11.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 11.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
    • 11.5.1. Hepatocytes
    • 11.5.2. Fibroblasts
    • 11.5.3. Keratinocytes
    • 11.5.4. Neurons
    • 11.5.5. Others
  • 11.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
  • 11.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
    • 11.7.1. Drug Development
    • 11.7.2. Toxicity testing
    • 11.7.3. Regenerative Medicine
    • 11.7.4. Others
  • 11.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
  • 11.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 11.9.1. Academic & Research Institutes
    • 11.9.2. Biotechnology companies
    • 11.9.3. Others
  • 11.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 11.11. Drivers and Restraints: Impact Analysis
  • 11.12. Market Attractiveness Analysis
    • 11.12.1. By Country
    • 11.12.2. By Cell Type
    • 11.12.3. By Application
    • 11.12.4. By End User
  • 11.13. Key Market Participants - Intensity Mapping
  • 11.14. Drivers and Restraints - Impact Analysis
  • 11.15. Key Mergers & Acquisitions

12. China Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 12.1. Introduction
  • 12.2. Key Regulations
  • 12.3. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
    • 12.3.1. Hepatocytes
    • 12.3.2. Fibroblasts
    • 12.3.3. Keratinocytes
    • 12.3.4. Neurons
    • 12.3.5. Others
  • 12.4. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
  • 12.5. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
    • 12.5.1. Drug Development
    • 12.5.2. Toxicity testing
    • 12.5.3. Regenerative Medicine
    • 12.5.4. Others
  • 12.6. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
  • 12.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 12.7.1. Academic & Research Institutes
    • 12.7.2. Biotechnology companies
    • 12.7.3. Others
  • 12.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 12.9. Drivers and Restraints: Impact Analysis
  • 12.10. Market Attractiveness Analysis
    • 12.10.1. By Cell Type
    • 12.10.2. By Application
    • 12.10.3. By End User
  • 12.11. Key Market Participants - Intensity Mapping
  • 12.12. Drivers and Restraints - Impact Analysis
  • 12.13. Key Mergers & Acquisitions

13. Middle East & Africa Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 13.1. Introduction
  • 13.2. Key Regulations
  • 13.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
    • 13.3.1. GCC Countries
    • 13.3.2. South Africa
    • 13.3.3. Rest of MEA
  • 13.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 13.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
    • 13.5.1. Hepatocytes
    • 13.5.2. Fibroblasts
    • 13.5.3. Keratinocytes
    • 13.5.4. Neurons
    • 13.5.5. Others
  • 13.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
  • 13.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
    • 13.7.1. Drug Development
    • 13.7.2. Toxicity testing
    • 13.7.3. Regenerative Medicine
    • 13.7.4. Others
  • 13.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
  • 13.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 13.9.1. Academic & Research Institutes
    • 13.9.2. Biotechnology companies
    • 13.9.3. Others
  • 13.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 13.11. Drivers and Restraints: Impact Analysis
  • 13.12. Market Attractiveness Analysis
    • 13.12.1. By Country
    • 13.12.2. By Cell Type
    • 13.12.3. By Application
    • 13.12.4. By End User
  • 13.13. Key Market Participants - Intensity Mapping
  • 13.14. Drivers and Restraints - Impact Analysis
  • 13.15. Key Mergers & Acquisitions

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis

  • 16.1. Market Structure by Tier of Companies
  • 16.2. Market Share Analysis (2024) for Top Players, By Region

17. Competition Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Company Deep Dive
    • 17.3.1. Thermo Fisher Scientific Inc.
      • 17.3.1.1. Overview
      • 17.3.1.2. Product and Application Portfolio
      • 17.3.1.3. Production Footprint
      • 17.3.1.4. Sales Footprint
      • 17.3.1.5. Channel Footprint
      • 17.3.1.6. Strategy
        • 17.3.1.6.1. Marketing Strategy
        • 17.3.1.6.2. Product Strategy
        • 17.3.1.6.3. Channel Strategy
    • 17.3.2. FUJIFILM Holdings Corporation (Cellular Dynamics)
      • 17.3.2.1. Overview
      • 17.3.2.2. Product and Application Portfolio
      • 17.3.2.3. Production Footprint
      • 17.3.2.4. Sales Footprint
      • 17.3.2.5. Channel Footprint
      • 17.3.2.6. Strategy
        • 17.3.2.6.1. Marketing Strategy
        • 17.3.2.6.2. Product Strategy
        • 17.3.2.6.3. Channel Strategy
    • 17.3.3. Horizon Discovery Group plc.
      • 17.3.3.1. Overview
      • 17.3.3.2. Product and Application Portfolio
      • 17.3.3.3. Production Footprint
      • 17.3.3.4. Sales Footprint
      • 17.3.3.5. Channel Footprint
      • 17.3.3.6. Strategy
        • 17.3.3.6.1. Marketing Strategy
        • 17.3.3.6.2. Product Strategy
        • 17.3.3.6.3. Channel Strategy
    • 17.3.4. Takara Bio Inc.
      • 17.3.4.1. Overview
      • 17.3.4.2. Product and Application Portfolio
      • 17.3.4.3. Production Footprint
      • 17.3.4.4. Sales Footprint
      • 17.3.4.5. Channel Footprint
      • 17.3.4.6. Strategy
        • 17.3.4.6.1. Marketing Strategy
        • 17.3.4.6.2. Product Strategy
        • 17.3.4.6.3. Channel Strategy
    • 17.3.5. Cell Applications, Inc.
      • 17.3.5.1. Overview
      • 17.3.5.2. Product and Application Portfolio
      • 17.3.5.3. Production Footprint
      • 17.3.5.4. Sales Footprint
      • 17.3.5.5. Channel Footprint
      • 17.3.5.6. Strategy
        • 17.3.5.6.1. Marketing Strategy
        • 17.3.5.6.2. Product Strategy
        • 17.3.5.6.3. Channel Strategy
    • 17.3.6. Lonza Group Ltd.
      • 17.3.6.1. Overview
      • 17.3.6.2. Product and Application Portfolio
      • 17.3.6.3. Production Footprint
      • 17.3.6.4. Sales Footprint
      • 17.3.6.5. Channel Footprint
      • 17.3.6.6. Strategy
        • 17.3.6.6.1. Marketing Strategy
        • 17.3.6.6.2. Product Strategy
        • 17.3.6.6.3. Channel Strategy

18. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Region

  • 18.1. Introduction/Key Findings
  • 18.2. Historical Market Size (US$ Bn) Trend Analysis By Region, 2020 - 2024
  • 18.3. Market Size (US$ Bn) Forecast By Region, 2025 - 2032
    • 18.3.1. North America
    • 18.3.2. Latin America
    • 18.3.3. Europe
    • 18.3.4. Asia Pacific
    • 18.3.5. Middle East & Africa
    • 18.3.6. China
  • 18.4. Market Attractiveness Analysis By Region

19. Global Induced Pluripotent Stem Cells Analysis 2020 - 2024 and Forecast 2025 - 2032, By Cell Type

  • 19.1. Introduction/Key Findings
  • 19.2. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
    • 19.2.1. Hepatocytes
    • 19.2.2. Fibroblasts
    • 19.2.3. Keratinocytes
    • 19.2.4. Neurons
    • 19.2.5. Others
  • 19.3. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
  • 19.4. Market Attractiveness Analysis By Cell Type

20. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Application

  • 20.1. Introduction/Key Findings
  • 20.2. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
    • 20.2.1. Drug Development
    • 20.2.2. Toxicity testing
    • 20.2.3. Regenerative Medicine
    • 20.2.4. Others
  • 20.3. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
  • 20.4. Market Attractiveness Analysis By Application

21. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By End User

  • 21.1. Introduction/Key Findings
  • 21.2. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 21.2.1. Academic & Research Institutes
    • 21.2.2. Biotechnology companies
    • 21.2.3. Others
  • 21.3. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 21.4. Market Attractiveness Analysis By End User

22. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 22.1. Market Value Share Analysis By All Segment
  • 22.2. Y-o-Y Growth Analysis By All Segment
  • 22.3. Absolute $ Opportunity

23. Assumptions and Acronyms

24. Research Methodology